| Market Cap | 27.50M | P/E | 11.27 | EPS this Y | - | Ern Qtrly Grth | 29.50% |
| Income | 5.75M | Forward P/E | - | EPS next Y | - | 50D Avg Chg | 1.00% |
| Sales | 6.65M | PEG | - | EPS past 5Y | -37.41% | 200D Avg Chg | 9.00% |
| Dividend | N/A | Price/Book | 0.65 | EPS next 5Y | - | 52W High Chg | -10.00% |
| Recommedations | - | Quick Ratio | 5.93 | Shares Outstanding | 9.39M | 52W Low Chg | 49.00% |
| Insider Own | 43.35% | ROA | 8.60% | Shares Float | 4.84M | Beta | 0.58 |
| Inst Own | 5.23% | ROE | 13.54% | Shares Shorted/Prior | -/- | Price | 2.93 |
| Gross Margin | 100.00% | Profit Margin | 86.52% | Avg. Volume | 170 | Target Price | - |
| Oper. Margin | 96.99% | Earnings Date | Apr 26 | Volume | 25 | Change | 0.00% |
Pinetree Capital Ltd. is a venture capital and private equity firm specializing in early, later stage venture, middle market, mature, later stage, turnaround and growth capital investments in micro and small cap companies. The firm prefers to invest in enterprise software, financial and healthcare industries. It typically invests in USA, Canada and Europe. The firm invests primarily in equities as well as debt and convertible securities. It takes minority stake in companies. It typically holds 8-12 investments, resulting in equity positions between 7% and 12% of assets which might exceed 20%. Pinetree Capital Ltd. was founded in 1992 and is based in Toronto, Canada with an additional office in Toronto, Canada.